MedPath

TWYNEO

These highlights do not include all the information needed to use TWYNEO safely and effectively. See full prescribing information for TWYNEO. TWYNEO (tretinoin and benzoyl peroxide) cream, 0.1%/3%, for topical use. Initial U.S. Approval: 2021

Approved
Approval ID

27208dff-e376-4c18-b56e-0a260f685a39

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 11, 2023

Manufacturers
FDA

Galderma Laboratories, L.P.

DUNS: 047350186

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

tretinoin and benzoyl peroxide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0299-5945
Application NumberNDA214902
Product Classification
M
Marketing Category
C73594
G
Generic Name
tretinoin and benzoyl peroxide
Product Specifications
Route of AdministrationTOPICAL
Effective DateJuly 11, 2023
FDA Product Classification

INGREDIENTS (2)

TretinoinActive
Quantity: 1 mg in 1 g
Code: 5688UTC01R
Classification: ACTIB
Benzoyl PeroxideActive
Quantity: 30 mg in 1 g
Code: W9WZN9A0GM
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TWYNEO - FDA Drug Approval Details